Tong, Alfred
April 2004
Asian Chemical News;4/5/2004, Vol. 10 Issue 440, p8
Trade Publication
Presents updates on the chemical industry as of April 5, 2004. Company that will be acquired by biotechnology company Amgen in California; Number of jobs that will be affected by the plan of Merck to reorganize its business in France; Forecast for the U.S. electronic chemicals markets in 2009.


Related Articles

  • Western Firms Respond to Low-Cost Pharma in China and India. Scott, Alex // Chemical Week;10/25/2006, Vol. 168 Issue 35, p35 

    The article reports that dramatic changes within the global pharmaceutical fine chemical manufacturing sector are likely to have negative affects on Western pharma fine chemical manufacturers. The changes include consolidations, group restructurings, and low-cost Asian competition. However,...

  • TOP STORIES.  // MondayMorning;11/22/2010, Vol. 18 Issue 43, p1 

    The article offers news briefs related to drug industry in the U.S. Amgen Inc. will acquire Actelion Ltd. A drug from Merck & Co. has helped in minimizing the complications of heart diseases. A gene-therapy treatment called Mydica which has been made by Celladon Corp. has helped patients with...

  • Restructuring in the chemical industry.  // Chemical Business;Feb2000, Vol. 14 Issue 2, p5 

    Focuses on restructuring in the chemical industry. Impacts of restructuring activities on chemical companies; Pace of mergers and acquisitions in the United States and Europe; Effects on smaller companies.

  • SNPE mulls Rhodia link in post-explosion refocus.  // European Chemical News;2/24/2003, Vol. 78 Issue 2041, p8 

    Focuses on the search of SNPE, the French state-owned chemicals and industrial group, for a merger or alliance as of March 23, 2003. Comments from communications vive president Bernard Roussell; Implication of the merger; Information on the restructuring efforts of the company.

  • 'New' Five-Division Merck Still Eager for Biotech Alliances. Young, Donna // BioWorld Today;9/1/2009, Vol. 20 Issue 168, p1 

    The article focuses on plans by Merck & Co. Inc to partner with biotechnology companies after it finalized its merger with Schering-Plough Corp. The combined entity would establish the Merck BioVentures division, which was created in December 2008 to pursue innovative and follow-on biologics...

  • Merck Confirms 2012 Full-Year Guidance.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article offers information on expectations of the company Merck on non GAAP earnings per share (EPS) and GAAP EPS for full-year 2012, including research and development expense but excluding acquisition related costs and restructuring programs costs. The company expects nonGAAP EPS to be in...

  • TOP STORIES FROM ICIS news. Gibson, Jane // ICIS Chemical Business;10/16/2006, Vol. 1 Issue 39, p4 

    The article presents an outlook for the chemical industry. Dutch chemicals major DSM is developing its innovation drive and looking to boost sales from new products. Meanwhile, consolidation in China's chemical industry is expected to be regionally focused and rapid. Also in the news, the...

  • CORPORATE.  // MondayMorning;4/11/2011, Vol. 18 Issue 14, p2 

    The article presents business news briefs. Merck & Co. Inc. has plans to acquire eye-treatment maker Inspire Pharmaceuticals Inc. to expand its ophthalmology business. Share prices of Edwards LifeSciences Corp. dropped after concerns regarding complication rates were raised by a study of the...

  • Consolidation on the cards says consultancy report. Cozier, Muriel // European Chemical News;3/17/2003, Vol. 78 Issue 2044, p17 

    Predicts the increase in consolidation and merger activity in the European chemical distribution sector in 2003, according to a report released by consultancy firm KPMG. Attributes of the projected increase.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics